The drug sulthiame reduces the number of breathing pauses and improves sleep quality in patients with obstructive sleep apnea, according to a European clinical study in which the University of ...
Obstructive sleep apnea (OSA) affects an estimated 85 million people in the US, and up to 3.9 million in the UK, and is characterized by pauses in breathing that are caused by the throat collapsing ...
At the LifeBridge Health ENT Sinus & Allergy Center, Dr. Alpen Patel helps patients get to the root of disrupted sleep. With ...
Experts say that if the new drug gets approved, it may lead to a big shift in how we treat the condition. By Caroline Hopkins Legaspi Tens of millions of people in the United States struggle with ...
A new study from the University of Missouri has helped scientists better understand how this happens. This discovery could ...
Central sleep apnea (CSA) is a sleep disorder that is less common than obstructive sleep apnea, but it does have some similarities. In the US, CSA is estimated to affect less than 1% of adults over 40 ...